𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor resistance to CD8+T cell-based therapeutic vaccination

✍ Scribed by Yujun Huang; Shivanee Shah; Liang Qiao


Publisher
Springer
Year
2007
Tongue
English
Weight
141 KB
Volume
55
Category
Article
ISSN
0004-069X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Tumor-reactive CD8+ T-cell clones in pat
✍ Julia Karbach; Sacha Gnjatic; Claudia Pauligk; Armin Bender; Markus Maeurer; Joa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 272 KB

## Abstract A major objective of peptide vaccination is the induction of tumor‐reactive CD8^+^ T‐cells. We have shown that HLA‐A2 positive cancer patients frequently develop an antigen‐specific CD8^+^ T‐cell response after vaccination with NY‐ESO‐1 peptides p157‐165/p157‐167. These T‐cells are high

Paradoxical enhancement of CD8 T cell-de
✍ Dev Karan; Arthur M. Krieg; David M. Lubaroff 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 371 KB 👁 1 views

## Abstract Generation of antigen‐specific CD8+ T cell responses is considered optimal for an effective immunotherapy against cancer. In this study, we provide a proof of principle that __in vitro__ observed diminished CD8+ T cell response provided a strong __in vivo__ tumor protection. Immunizatio

Blockade of TGF-β enhances tumor vaccine
✍ Shun Takaku; Masaki Terabe; Elena Ambrosino; Judy Peng; Scott Lonning; John M. M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 264 KB

## Abstract Though TGF‐β inhibition enhances antitumor immunity mediated by CD8^+^ T cells in several tumor models, it is not always sufficient for rejection of tumors. In this study, to maximize the antitumor effect of TGF‐β blockade, we tested the effect of anti‐TGF‐β combined with an irradiated

Therapeutic vaccination against chronic
✍ Allan J Zajac; Kaja Murali-Krishna; Joseph N Blattman; Rafi Ahmed 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 740 KB

The goal of therapeutic vaccination is to elicit an antiviral immune response within persistently infected individuals and consequently eradicate the infection. CD8+ T cells are potent mediators of viral clearance; however, during chronic infections CD4+ T cell help is required to sustain antiviral